Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2012
12/20/2012WO2012173214A1 Azepane compound
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173099A1 Endothelial-lipase-inhibiting amino derivative
12/20/2012WO2012173010A1 Platelet-derived growth factor (pdgf)-bb production-enhancing agent, and stem cell stabilizer containing same
12/20/2012WO2012171487A1 Aryloxy quinolines derivatives and the treating use thereof
12/20/2012US20120323200 Cooling composition and absorbent article comprising the same
12/20/2012US20120322874 Pharmaceutical Uses
12/20/2012US20120322863 Prevention of and countermeasures against mitochondrial disease
12/20/2012US20120322850 Trpm-2 antisense therapy
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322105 Growth factor
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321605 Artificial saliva comprising hyalulonic acid
12/20/2012US20120321599 Herpes virus strains
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/19/2012EP2535053A1 Mitochondrial function improver
12/19/2012EP2533801A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention
12/19/2012EP2533786A2 Methods and compositions to improve mechanical resistance of teeth
12/19/2012EP2533780A1 5-ht4 receptor agonists for the treatment of dementia
12/19/2012CN102834384A Oxazine derivative
12/19/2012CN102827738A Pogostemon health-care wine for relieving summer-heat
12/19/2012CN102827713A Two-flower three-leaf beer
12/19/2012CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor
12/19/2012CN102824615A Medicinal composition used for cold evil caused faint symptoms of domestic animals
12/18/2012US8334323 Alkylene oxide-capped secondary alcohol alkoxylates useful as surfactants
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8333193 Dry powder inhalation system for transpulmonary administration
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2596003C Six-membered heterocyclic compound and use thereof
12/18/2012CA2514552C Adjuvant used in dielectric heating-assisted cancer treatment, and cancer treatment method
12/18/2012CA2460692C Pesticidal formulations
12/18/2012CA2363486C Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
12/13/2012WO2012169827A2 Composition for eyelash growth
12/13/2012WO2012169649A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/13/2012WO2012169579A1 Heterocyclic carboxylic acid ester derivative
12/13/2012WO2012169571A1 Novel n-(pyridin-2-yl)alkanamide derivative and ship2 inhibitor containing same as an active ingredient
12/13/2012WO2012169541A1 Trpv3 activator
12/13/2012WO2012167882A1 Composition for oral delivery of biologically-active substances
12/13/2012WO2012167733A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012WO2012167600A1 A heterocyclic [b]pyridone compound, intermediates thereof, method of preparation and uses
12/13/2012WO2012167423A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012US20120316354 Pasteurisation process for microbial cells and microbial oil
12/13/2012US20120316241 Remedy for cartilage-related diseases
12/13/2012US20120316113 Fgf based fibrin binding peptides
12/13/2012US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
12/13/2012US20120315286 Compositions and methods related to tim 3, a th1-specific cell surface molecule
12/13/2012US20120315263 Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases
12/13/2012US20120315251 Postpartum cells derived from umbilical tissue and methods of making and using the same
12/13/2012US20120315223 Compositions for oral use and methods for treating the oral mucosa, lips, and perioral regions
12/13/2012CA2836227A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012CA2833507A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/12/2012EP2532681A1 Anti-ILT7 antibody
12/12/2012EP2532656A1 Gpr119 agonist
12/12/2012EP2532368A1 "Composition for oral delivery of biologically-active substances"
12/12/2012EP2532351A1 Agent for improving motility function
12/12/2012EP2532350A1 Pharmaceutical combination of a glucocorticoid receptor antagonist and a cortisol synthesis inhibitor for treating cushing's syndrome
12/12/2012EP2532241A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/12/2012CN1678734B Differentiation modulating agents and uses thereof
12/12/2012CN102822163A Crth2 modulators
12/12/2012CN102822154A Heteroarylcarboxylic acid ester derivative
12/12/2012CN102821773A Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient
12/12/2012CN102816130A Thiazole Compound and Use Thereof
12/12/2012CN102816113A Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
12/12/2012CN102813843A Heat-clearing and stomach-harmonizing tablets
12/12/2012CN102813680A Pharmaceutical composition for auxiliary radiation therapy
12/12/2012CN102813670A Application of lycium barbarum polysaccharide in preparing medicine for preventing and treating chronic stress
12/12/2012CN101747226B N-oxalic acid acyl amino acid derivatives and N-oxalic acid acyl dipeptide derivatives as well as applications thereof in preparation of consciousness-promoted drugs
12/12/2012CN101507735B Oyster calcining technological process
12/12/2012CN101486677B 5HT2C receptor modulators
12/11/2012US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use
12/11/2012US8329928 Compounds, compositions and methods
12/11/2012US8329919 Salt hydrates
12/11/2012US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329690 Cyclothiocarbamate derivatives as progesterone receptor modulators
12/11/2012US8329687 Pyridooxazepine derivative and use thereof
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329463 RNA interference mediating small RNA molecules
12/11/2012US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
12/11/2012US8329171 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
12/11/2012US8329144 Diagnostic and therapeutic epitope, and transgenic plant
12/11/2012CA2552679C Tulobuterol adhesive patch
12/11/2012CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/11/2012CA2451980C 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune disorders
12/06/2012WO2012165610A1 Composition for maintaining or improving skin barrier function
12/06/2012WO2012165547A1 Method for manufacturing pyrazole derivative
12/06/2012WO2012165399A1 Imidazopyridine compound
12/06/2012WO2012165398A1 Cycloalkyloxybiaryl compound
12/06/2012WO2012165394A1 Anti-tumor agent
12/06/2012WO2012165314A1 Amide compound
12/06/2012US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences
12/06/2012US20120309696 Acth antagonist peptides
12/06/2012US20120308669 Chocolate candies fortified with natural amino acids and/or herbal nutrients for relief of insomnia, pms, and difficulty concentrating
12/06/2012US20120308545 Crystallized Oxalate Decarboxylase and Methods of Use
12/06/2012US20120308508 Microgel compositions
12/06/2012CA2836202A1 Imidazopyridine compounds
12/05/2012EP2528920A2 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
12/05/2012EP2528595A1 Compounds for use in the treatment of diseases
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 1564